Global Trust Asset Management LLC lowered its stake in Cooper Companies Inc (NYSE:COO) by 86.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 279 shares of the medical device company’s stock after selling 1,731 shares during the period. Global Trust Asset Management LLC’s holdings in Cooper Companies were worth $71,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CENTRAL TRUST Co boosted its position in Cooper Companies by 17.1% during the 4th quarter. CENTRAL TRUST Co now owns 513 shares of the medical device company’s stock valued at $131,000 after acquiring an additional 75 shares in the last quarter. Federated Investors Inc. PA boosted its position in Cooper Companies by 785.1% during the 3rd quarter. Federated Investors Inc. PA now owns 243,458 shares of the medical device company’s stock valued at $67,475,000 after acquiring an additional 215,951 shares in the last quarter. Marshall Wace North America L.P. boosted its position in Cooper Companies by 875.3% during the 3rd quarter. Marshall Wace North America L.P. now owns 144,900 shares of the medical device company’s stock valued at $40,159,000 after acquiring an additional 130,043 shares in the last quarter. Vanguard Group Inc boosted its position in Cooper Companies by 0.6% during the 3rd quarter. Vanguard Group Inc now owns 5,041,468 shares of the medical device company’s stock valued at $1,397,243,000 after acquiring an additional 31,280 shares in the last quarter. Finally, Morgan Stanley boosted its position in Cooper Companies by 734.7% during the 3rd quarter. Morgan Stanley now owns 177,658 shares of the medical device company’s stock valued at $49,238,000 after acquiring an additional 156,373 shares in the last quarter.
In other news, Director Allan E. Rubenstein acquired 348 shares of the firm’s stock in a transaction that occurred on Monday, December 10th. The stock was bought at an average cost of $241.59 per share, for a total transaction of $84,073.32. Following the acquisition, the director now directly owns 4,524 shares in the company, valued at $1,092,953.16. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is owned by insiders.
COO stock opened at $261.49 on Friday. Cooper Companies Inc has a 52-week low of $216.47 and a 52-week high of $283.18. The company has a market cap of $12.71 billion, a PE ratio of 22.74, a price-to-earnings-growth ratio of 2.03 and a beta of 0.83. The company has a quick ratio of 1.16, a current ratio of 2.03 and a debt-to-equity ratio of 0.60.
Cooper Companies (NYSE:COO) last released its earnings results on Thursday, December 6th. The medical device company reported $2.87 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.96 by ($0.09). Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%. The business had revenue of $651.50 million for the quarter, compared to analysts’ expectations of $645.25 million. During the same quarter in the previous year, the business posted $2.65 earnings per share. Cooper Companies’s revenue for the quarter was up 16.0% on a year-over-year basis. Sell-side analysts predict that Cooper Companies Inc will post 11.55 EPS for the current year.
The company also recently disclosed a semiannual dividend, which will be paid on Friday, February 8th. Investors of record on Tuesday, January 22nd will be issued a $0.03 dividend. The ex-dividend date of this dividend is Friday, January 18th. This represents a yield of 0.02%. Cooper Companies’s payout ratio is currently 0.52%.
TRADEMARK VIOLATION WARNING: “Global Trust Asset Management LLC Has $71,000 Stake in Cooper Companies Inc (COO)” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4072243/global-trust-asset-management-llc-has-71000-stake-in-cooper-companies-inc-coo.html.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: What is a Candlestick Chart?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.